Lina Benson

5.7k total citations
84 papers, 2.9k citations indexed

About

Lina Benson is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Lina Benson has authored 84 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Cardiology and Cardiovascular Medicine, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Lina Benson's work include Heart Failure Treatment and Management (50 papers), Cardiovascular Function and Risk Factors (22 papers) and Cardiac pacing and defibrillation studies (20 papers). Lina Benson is often cited by papers focused on Heart Failure Treatment and Management (50 papers), Cardiovascular Function and Risk Factors (22 papers) and Cardiac pacing and defibrillation studies (20 papers). Lina Benson collaborates with scholars based in Sweden, United States and Italy. Lina Benson's co-authors include Lars H. Lund, Ulf Dahlström, Gianluigi Savarese, Leif Friberg, Gregory Y.H. Lip, Magnus Edner, Magnus Edner, Cecilia Linde, Carolyn S.P. Lam and Tiew‐Hwa Katherine Teng and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Lina Benson

78 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lina Benson Sweden 32 2.3k 341 339 318 161 84 2.9k
Alexander C. Fanaroff United States 20 942 0.4× 407 1.2× 214 0.6× 325 1.0× 207 1.3× 104 1.8k
Morten Schou Denmark 30 1.4k 0.6× 331 1.0× 296 0.9× 436 1.4× 202 1.3× 169 3.0k
Jawad H. Butt Denmark 27 1.3k 0.6× 335 1.0× 262 0.8× 223 0.7× 146 0.9× 192 2.7k
Ty J. Gluckman United States 22 1.2k 0.5× 475 1.4× 208 0.6× 276 0.9× 115 0.7× 72 2.3k
Melissa A. Greiner United States 31 1.6k 0.7× 365 1.1× 297 0.9× 165 0.5× 57 0.4× 109 2.5k
Ayodele Odutayo Canada 23 1.5k 0.7× 455 1.3× 271 0.8× 250 0.8× 149 0.9× 60 3.3k
Pierpaolo Pellicori United Kingdom 35 2.6k 1.1× 696 2.0× 596 1.8× 370 1.2× 306 1.9× 183 4.3k
Martin J. Holzmann Sweden 31 1.8k 0.8× 692 2.0× 409 1.2× 380 1.2× 503 3.1× 154 3.2k
Abhishek Sharma United States 22 1.1k 0.5× 425 1.2× 188 0.6× 104 0.3× 187 1.2× 99 1.8k
Thao Huynh Canada 26 1.7k 0.7× 600 1.8× 178 0.5× 134 0.4× 403 2.5× 120 2.5k

Countries citing papers authored by Lina Benson

Since Specialization
Citations

This map shows the geographic impact of Lina Benson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Benson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Benson more than expected).

Fields of papers citing papers by Lina Benson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lina Benson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Benson. The network helps show where Lina Benson may publish in the future.

Co-authorship network of co-authors of Lina Benson

This figure shows the co-authorship network connecting the top 25 collaborators of Lina Benson. A scholar is included among the top collaborators of Lina Benson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lina Benson. Lina Benson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chouairi, Fouad, Marat Fudim, Gianluigi Savarese, et al.. (2025). Utility of Loop Diuretics as a Marker of Risk in Clinical Trials of Heart Failure with Preserved Ejection Fraction: Analysis from the Swedish Heart Failure Registry. European Journal of Heart Failure. 27(6). 972–978. 2 indexed citations
2.
Faxén, Ulrika Ljung, Lina Benson, Giuseppe Rosano, et al.. (2025). Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry. Journal of the American Heart Association. 14(6). e037502–e037502. 4 indexed citations
3.
Tomasoni, Daniela, Lina Benson, Alessandro Villaschi, et al.. (2025). Cardiac Resynchronization Therapy for Enabling Guideline-Directed Medical Therapy Optimization in Heart Failure. European Journal of Heart Failure. 27(10). 1820–1833.
4.
Wändell, Per, Lina Benson, Gianluigi Savarese, et al.. (2024). The association between anemia, hospitalization, and all-cause mortality in patients with heart failure managed in primary care: An analysis of the Swedish heart failure registry. Archives of Gerontology and Geriatrics. 129. 105645–105645. 2 indexed citations
5.
Brenton, J. Nicholas, Suzan L. Carmichael, Moses Rodriguez, et al.. (2024). Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. Multiple Sclerosis Journal. 30(8). 1056–1065.
6.
Wallner, Markus, Davide Stolfo, Gianfranco Sinagra, et al.. (2024). Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries. European Heart Journal - Cardiovascular Pharmacotherapy. 10(4). 296–306. 3 indexed citations
7.
Schrage, Benedikt, Lars H. Lund, Lina Benson, et al.. (2023). Association Between a Hospitalization for Heart Failure and the Initiation/Discontinuation of Guideline-Recommended Treatments: An Analysis from the Swedish Heart Failure Registry. European Journal of Heart Failure. 25(7). 1132–1144. 11 indexed citations
8.
Chioncel, Ovidiu, Lina Benson, María G. Crespo‐Leiro, et al.. (2023). Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry. European Journal of Preventive Cardiology. 30(13). 1346–1358. 17 indexed citations
9.
Schrage, Benedikt, Lars H. Lund, Lina Benson, et al.. (2022). Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality. European Journal of Heart Failure. 24(7). 1212–1222. 11 indexed citations
10.
Lund, Lars H., Gianluigi Savarese, Ashwin Venkateshvaran, et al.. (2021). Eligibility of Patients with Heart Failure with Preserved Ejection Fraction for Sacubitril/Valsartan According to the PARAGON-HF Trial. ESC Heart Failure. 9(1). 164–177. 5 indexed citations
11.
Cooper, Lauren B., Lina Benson, Robert J. Mentz, et al.. (2020). Association Between Potassium Level and Outcomes in Heart Failure with Reduced Ejection Fraction: A Cohort Study from the Swedish Heart Failure Registry. European Journal of Heart Failure. 22(8). 1390–1398. 37 indexed citations
12.
Koh, Angela S., Wan Ting Tay, Tiew‐Hwa Katherine Teng, et al.. (2017). A Comprehensive Population-Based Characterization of Heart Failure with Mid-Range Ejection Fraction. European Journal of Heart Failure. 19(12). 1624–1634. 211 indexed citations
13.
Löfgren, Monika, et al.. (2016). Assessment and treatment at a pain clinic: A one-year follow-up of patients with chronic pain. Scandinavian Journal of Pain. 17(1). 233–242. 12 indexed citations
14.
Braunschweig, Frieder, Cecilia Linde, Lina Benson, et al.. (2016). New York Heart Association Functional Class, Qrs Duration, and Survival in Heart Failure with Reduced Ejection Fraction: Implications for Cardiac Resychronization Therapy. European Journal of Heart Failure. 19(3). 366–376. 25 indexed citations
15.
Karlsson, Eva, et al.. (2016). Medication errors as malpractice-a qualitative content analysis of 585 medication errors by nurses in Sweden. BMC Health Services Research. 16(1). 431–431. 50 indexed citations
16.
Belman, Anita, Lauren Krupp, Cody S. Olsen, et al.. (2016). Demographic and Clinical Characteristics of 490 Children and Adolescents with Multiple Sclerosis (MS): US Network of Pediatric MS Centers’ Experience (S29.004). Neurology. 86(16_supplement). 1 indexed citations
17.
Lund, Lars H., Lina Benson, Marcus Ståhlberg, et al.. (2014). Age, Prognostic Impact of QRS Prolongation and Left Bundle Branch Block, and Utilization of Cardiac Resynchronization Therapy: Findings from 14 713 Patients in the Swedish Heart Failure Registry. European Journal of Heart Failure. 16(10). 1073–1081. 47 indexed citations
18.
Lund, Lars H., Lina Benson, Ulf Dahlström, & Magnus Edner. (2012). Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction. JAMA. 308(20). 2108–2108. 129 indexed citations
19.
Lund, Lars H., Juliane Jurga, Magnus Edner, et al.. (2012). Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. European Heart Journal. 34(7). 529–539. 115 indexed citations
20.
Benson, Lina, Kiran Maski, Sanjeev V. Kothare, & Blaise F. D. Bourgeois. (2010). New Onset Epilepsy in Prader-Willi Syndrome: Semiology and Literature Review. Pediatric Neurology. 43(4). 297–299. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026